 Connection
Ihab Kamel to Radiopharmaceuticals
This is a "connection" page, showing publications Ihab Kamel has written about Radiopharmaceuticals.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.345 |
|
|
|
-
Li A, Liang L, Liang P, Hu Y, Xu C, Hu X, Shen Y, Hu D, Li Z, Kamel IR. Assessment of renal fibrosis in a rat model of unilateral ureteral obstruction with diffusion kurtosis imaging: Comparison with a-SMA expression and 18F-FDG PET. Magn Reson Imaging. 2020 02; 66:176-184.
Score: 0.150
-
Gulaldi NC, Xia J, Feng T, Hong K, Mathews WB, Ruben D, Kamel IR, Tsui BM, Szabo Z. Modeling of the renal kinetics of the AT1 receptor specific PET radioligand [11C]KR31173. Biomed Res Int. 2013; 2013:835859.
Score: 0.099
-
Subhawong TK, Subhawong AP, Kamel I. Sclerosing angiomatoid nodular transformation of the spleen: multimodality imaging findings and pathologic correlate. J Comput Assist Tomogr. 2010 Mar-Apr; 34(2):206-9.
Score: 0.078
-
Hong K, McBride JD, Georgiades CS, Reyes DK, Herman JM, Kamel IR, Geschwind JF. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol. 2009 Mar; 20(3):360-7.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|